Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 44 Neoplasms 39 Fatigue 29 Depression 25 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 16 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Lymphoma, Large B-Cell, Diffuse 14 Lung Neoplasms 14 Colorectal Neoplasms 14 Pain 13 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Anxiety Disorders 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Hairy Cell 10 Blast Crisis 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Myeloid, Accelerated Phase 9 Head and Neck Neoplasms 9

Interventions

Gemcitabine 7 pembrolizumab 4 atezolizumab 3 Trastuzumab 3 Sunitinib 3 Carboplatin 3 enfortumab vedotin 2 dodecyl maltoside 2 cabozantinib 2 Water 2 Standard of Care 2 Pemetrexed 2 Paclitaxel 2 Cisplatin 2 Cetuximab 2 Bevacizumab 2 vinflunine 1 valrubicin 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 poly ICLC 1 niraparib 1 montanide ISA 51 1 lenvatinib 1 flt3 ligand protein 1 delta 24-sterol reductase 1 daratumumab 1 avelumab 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡